Vigil Neuroscience, Inc. logo

Vigil Neuroscience, Inc.

NASDAQ:VIGL

Overview | Financials
Company Name Vigil Neuroscience, Inc.
Symbol VIGL
Currency USD
Price 3.99
Market Cap 158,193,657
Dividend Yield 0%
52-week-range 2.47 - 9.24
Industry Biotechnology
Sector Healthcare
CEO Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Website https://www.vigilneuro.com

An error occurred while fetching data.

About Vigil Neuroscience, Inc.

Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2)

Related Stocks

Wave Life Sciences Ltd. logo

Wave Life Sciences Ltd.

WVE

14.61 USD

SAB Biotherapeutics, Inc. logo

SAB Biotherapeutics, Inc.

SABS

2.76 USD

BioAtla, Inc. logo

BioAtla, Inc.

BCAB

1.85 USD

Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc.

ETON

8.4 USD

Akumin Inc. logo

Akumin Inc.

AKU

0.289 USD

Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc.

ASMB

18.1 USD

Lipocine Inc. logo

Lipocine Inc.

LPCN

5.04 USD

aTyr Pharma, Inc. logo

aTyr Pharma, Inc.

LIFE

1.9 USD

Financials

Numbers are in millions USD

Numbers are in millions USD